Table 1.

Change of PPT- and PPD-type ginsenoside concentration in CRISPR/Cas9-mediated mutant lines

Line	Ginsenoside concentration (mg/g)							Total
	PPT-type			PPD-type
	Rg1	Re	Rf	Rb1	Rc	Rb2	Rd
Wild-type	2.84 ± 0.13	1.13 ± 0.13	0.52 ± 0.04	1.53 ± 0.14	0.20 ± 0.05	0.31 ± 0.02	0.15 ± 0.01	6.68 ± 0.52
Cr4 (sgRNA1)	-	-	-	4.62 ± 0.12	0.42 ± 0.02	0.95 ± 0.03	0.37 ± 0.03	6.36 ± 0.20
Cr7 (sgRNA1)	-	-	-	4.43 ± 0.17	0.36 ± 0.01	0.96 ± 0.02	0.36 ± 0.03	6.11 ± 0.23
Cr14 (sgRNA1)	-	-	-	4.58 ± 0.21	0.44 ± 0.02	0.78 ± 0.04	0.48 ± 0.02	6.24 ± 0.29
Cr3 (sgRNA4)	0.38 ± 0.02	0.22 ± 0.03	-	3.76 ± 0.19	0.34 ± 0.03	0.92 ± 0.13	0.33 ± 0.02	5.45 ± 0.42
Cr8 (sgRNA4)	0.15 ± 0.03	0.09 ± 0.01	0.14 ± 0.01	3.67 ± 0.31	0.23 ± 0.04	1.06 ± 0.07	0.44 ± 0.01	5.78 ± 0.48